about
Emerging Roles of Viroporins Encoded by DNA Viruses: Novel Targets for Antivirals?Human papillomavirus induced transformation in cervical and head and neck cancershrHPV E5 oncoprotein: immune evasion and related immunotherapies.Human papillomavirus 16 E5 modulates the expression of host microRNAsNonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors.Cell culture model predicts human disease: Altered expression of junction proteins and matrix metalloproteinases in cervical dysplasiaRapamycin inhibits anal carcinogenesis in two preclinical animal models.The E5 proteinsHPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.Papillomavirus E5: the smallest oncoprotein with many functions.Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in VivoTherapeutic Vaccine Strategies against Human Papillomavirus.Human papillomaviruses: shared and distinct pathways for pathogenesisLaboratory and clinical aspects of human papillomavirus testingInactivating all three rb family pocket proteins is insufficient to initiate cervical cancer.Requirement for stromal estrogen receptor alpha in cervical neoplasiaVirology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinomaHuman papillomavirus infections: warts or cancer?Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk virusesViral takeover of the host ubiquitin system.An unhealthy relationship: viral manipulation of the nuclear receptor superfamily.Biology of human papillomavirus infections in head and neck carcinogenesis.Human papillomavirus E5 oncoproteins bind the A4 endoplasmic reticulum protein to regulate proliferative ability upon differentiation.Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers.The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design.Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle.Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.Inhibition of TGF-β and NOTCH Signaling by Cutaneous Papillomaviruses.Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.Human papillomavirus E5 oncoprotein: function and potential target for antiviral therapeuticsAlkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5Papillomaviruses and Endocytic Trafficking
P2860
Q26778969-25AE27F3-4C6C-4DB9-A077-EFC76E7FB215Q27003141-F1826FC5-85D2-47E7-901A-CEA2D26E8A8DQ33730462-291D9DC7-CF2B-453A-B19D-04C9297D7C3CQ33958050-53555A73-ACC0-4278-9DE7-C7AD915DDF4BQ34043004-B29CCF05-A2F8-4FC0-AF5C-57BBF463B5F5Q34256338-58DE381C-492A-452B-984E-1F2023651632Q34365878-31CCE917-E5A3-440E-87C6-4FC0BBA8D1AFQ34679829-65CD98B0-348C-432B-B4D2-60C5F860B956Q34754347-42AEA2BD-84C1-44A2-9A24-5B215A5D54E9Q34883792-179B5D06-7BE8-4474-BE4A-95770AA37D08Q35642759-A21302CC-5A46-4A8B-8669-F96D6172FB1EQ35813800-DEF13027-EDFC-402D-8320-6D277A9A1C90Q35826752-3621D133-ABE1-4636-8D14-CEAA93C2367AQ36236896-5235B546-5052-44A7-AEAD-29BF41CEBDA2Q36311573-8A3A87ED-6C6F-4CD4-99E6-63D1D97D0B52Q36322847-281B1165-3AAC-4206-9464-9C61B37B1761Q36522072-877E2419-C24C-4693-9217-64B5310CD744Q36607707-C0D3E231-9C1D-47C4-90FC-712F65E5EA86Q36938528-3BEB5E79-8196-4357-B0CE-343337AA4249Q36989890-8A2C6EF9-570D-4264-89BD-3872EBB54210Q37918803-D6294647-74AE-4510-8880-1C6040349F94Q37940570-4D70CBFF-7853-406D-A309-06FC5016522CQ38025306-11909F5D-E2AB-4445-AB6A-69D93C44A8BEQ38311763-5E520EA7-A477-4B34-BF0A-A4219425CB5BQ38449589-5AFE6CE0-1A87-4D78-9BAC-EE5B7BAB6B31Q38875247-1255EA22-4B29-4E80-882D-046A4AFE6082Q39076137-7F5E048E-0D79-4901-8DFC-C750E9448E04Q40444191-88D9B59B-5322-4A90-B4E9-BE10FA27764FQ41837402-B68F3B79-A3DA-4D81-BDF9-85FFBA48ABE8Q42218961-0D08B55A-99AF-4B3B-9CEF-0B0917EEDF86Q47118787-8FE81F56-2A94-4566-9239-327EF9100564Q53275556-D4C8F3FD-0EBD-4D18-92DB-C243FC82FBC0Q54243472-D9BDB689-FA14-4FA4-BEE9-12FCBE0E7689Q54250476-14893EBF-FCBF-40AF-AAE5-E10C09B541AFQ54937688-F34352E4-E340-4729-8925-C070BAE328BFQ58420548-A657DD06-D22D-44EA-82EE-8D94D21BAA27Q58420668-85155A4E-3EB5-44D6-A3AD-D71544C28668Q58764248-9B7270B0-24CC-4195-894E-69E341644F20
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A role for HPV16 E5 in cervical carcinogenesis.
@ast
A role for HPV16 E5 in cervical carcinogenesis.
@en
type
label
A role for HPV16 E5 in cervical carcinogenesis.
@ast
A role for HPV16 E5 in cervical carcinogenesis.
@en
prefLabel
A role for HPV16 E5 in cervical carcinogenesis.
@ast
A role for HPV16 E5 in cervical carcinogenesis.
@en
P2093
P2860
P1433
P1476
A role for HPV16 E5 in cervical carcinogenesis.
@en
P2093
Henry C Pitot
John P Maufort
Paul F Lambert
P2860
P304
P356
10.1158/0008-5472.CAN-09-3436
P407
P577
2010-03-23T00:00:00Z